Essential R&D knowledge from the leader in
predictive biosimulation
Thomson Scientific is able to supply exclusive
Target reports from Entelos Inc, the leader in predictive
biosimulation, including specially-compiled custom
reports for your own lead compounds.
ABOUT ENTELOS
Entelos develops computer models of human physiology,
employing its unique PhysioLab® technology to
create sophisticated ‘virtual patients’ that
accurately predict the effects and efficacy of candidate
drugs and can also give indications on liability
and toxicology.
Based on manual analysis of thousands of peer-reviewed
journal articles, constantly updated, and representative
of the disease population, these ‘virtual patients’ can
provide quick, cost-effective predictive modeling
for a wide variety of diseases.
In each available therapy area, the Entelos Target
reports condense the company’s simulation data
and results into knowledge essential for all organizations
and scientists involved in pharmaceutical and biotechnology
research and development.
AVAILABLE REPORT TYPES
Discovery report
For your chosen therapy area, this report indicates
how hard you need to hit a target to ensure the
efficacy of a candidate drug. It provides a unique
perspective to help focus your discovery efforts,
increase efficiency, and aid in developing new
hypotheses.
Clinical report
For your chosen therapy area, this report indicates
the optimal compound characteristics of a candidate
drug (how much to give, how to measure its effects).
It is compiled especially for those responsible
for advancing compounds into clinical trials. By
modeling long-term clinical trials, it can help
you to determine which patient subgroups will benefit
most.
Commercial report
For your chosen therapy area, this report indicates
how good a candidate drug needs to be in order
to achieve approval and market share. It enables
you to differentiate your compound in the market,
and helps to identify potential risks and liabilities.
Custom report
We can create a tailored, specially-compiled report
for your own lead compounds. By generating your
own custom report, you can gain novel insights
into how your drug performs against the market
leaders.
